Reuters
  A massive project that aims to compress what is typically 10 years of  vaccine development  and testing into a matter of months is being planned.
  The U.S. effort involving more than 100,000 volunteers and a half dozen or so of the most  promising vaccine candidates  aims to deliver a safe and effective vaccine by the end of 2020, scientists leading the program said.
  To get there,  leading vaccine makers  have agreed to share data and lend the use of their clinical trial networks to competitors if necessary, the scientists said.
  Read the whole story here. 
 